Kothari Fermentation and Biochem Limited (KFBL) Fair Value & Analysis
Consumer Non-Cyclicals · IN · Market cap ₹689M
Fair value as of: Jul 5, 2026
From 2 valuation models · updated today
Share price +10.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹34.01 – ₹68.23 · fair‑value band ₹10.54 – ₹38.72 · the ₹45.92 price screens above the ₹24.63 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Kothari Fermentation and Biochem Limited (KFBL) currently trades at ₹45.92, while our model-based Fair Value estimate is ₹24.63 — implying the stock looks roughly 46.4% overvalued today. We read business quality at 47/100 (below-average quality), in the Consumer Non-Cyclicals sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Kothari Fermentation and Biochem Limited generated revenue of ₹1.1B at a net margin of -2.7%. Revenue grew 0.9% year over year. It earns a return on equity of -5.4%. Net debt stands at ₹476M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹10.54 (bear case) to ₹38.72 (bull case); at ₹45.92, the current price sits above that range. The share trades about 34% below its 52-week high and 52% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 36% fair-value upside — at -46%, KFBL screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
Kothari Fermentation and Biochem Limited manufactures and sells yeast and its derivatives in India. It offers distiller's instant yeast for use in alcohol fermentation; fresh, instant, and inactive dried yeast for use in the food industry; yeast extract powder and inactive dried yeast for use in the pharmaceutical industry; and live yeast and oligo saccharides for use in the veterinary industry. The company offers its products under the Sunrise, KF, and Four Seasons brand names. Kothari Fermentation and Biochem Limited also exports its products to various countries. The company was incorporated in 1990 and is based in New Delhi, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Kothari Fermentation and Biochem Limited reported revenue of ₹1.1B in FY2026 versus ₹970M in FY2022, a compound +3.7%/yr. Reported net income was −₹29.9M in FY2026.
Is KFBL fairly valued? → Check now
Similar stocks
10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| FB FB | 49.00 PHP | 44.00 PHP | -10% |
| URC URC | 59.00 PHP | 36.52 PHP | -38% |
| MONDE MONDE | 7.00 PHP | 1.43 PHP | -80% |
| CNPF CNPF | 26.75 PHP | 56.29 PHP | +110% |
| DNL DNL | 3.70 PHP | 5.04 PHP | +36% |
| RFM RFM | 5.49 PHP | 10.59 PHP | +93% |
| AXLM AXLM | 2.57 PHP | 2.33 PHP | -9% |
| Helixmith Co 084990 | 4,255 KRW | 723.03 KRW | -83% |
| EASY BIO,Inc. 353810 | 6,250 KRW | 16,375 KRW | +162% |
| ANI ANI | 0.4800 PHP | 0.9200 PHP | +92% |
Explore undervalued stocks
Frequently asked questions
Is Kothari Fermentation and Biochem Limited (KFBL) undervalued?
What is the fair value of KFBL?
What is the quality score of KFBL?
What is the revenue of Kothari Fermentation and Biochem Limited (KFBL)?
What is the net profit margin of KFBL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.